TrialInternational wound journal2016

Adalimumab treatment leads to reduction of tissue tumor necrosis factor-alpha correlated with venous leg ulcer improvement: a pilot study.

Joshua D Fox et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.